The Optimal Sequential Therapy After Long Term Denosumab Treatment
NCT05091099
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
zoledronate
DRUG:
Alendronate and Zoledronate
Sponsor
National Taiwan University Hospital